Ganzhou Hemay Pharmaceutical Co., Ltd

This small, early-stage study aimed to understand how a potential new psoriasis pill, Hemay005, is processed by the body in people with different levels of kidney function. It involved 26 adults with normal, mild, or moderate kidney impairment who took a single dose. The main goa…

This small, completed study aimed to understand how a potential new psoriasis drug, Hemay005, interacts with a common sedative (midazolam) in the body. It involved 20 healthy adults to check if the drug affects heart rhythm and measures of inflammation. The main goal was to gathe…